Allergy Clinical Trials

125 recruitingLast updated: June 18, 2026

There are 125 actively recruiting allergy clinical trials across 25 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, Madrid, Spain, Naples, Italy. Updated daily from ClinicalTrials.gov.


Allergy Trials at a Glance

125 actively recruiting trials for allergy are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 44 trials, with the heaviest enrollment activity in Boston, Madrid, and Naples. Lead sponsors running allergy studies include National Institute of Allergy and Infectious Diseases (NIAID), Chinese University of Hong Kong, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About Allergy Clinical Trials

Looking for clinical trials for Allergy? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Allergy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Allergy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 125 trials

Recruiting
Phase 4

Allergy Delabeling in Antibiotic Stewardship - Intervention

Hematologic MalignancyBeta Lactam Allergy
Abramson Cancer Center at Penn Medicine3,800 enrolled1 locationNCT07133074
Recruiting
Phase 2

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

Ig-E Mediated Food Allergy
RAPT Therapeutics, Inc.100 enrolled31 locationsNCT07220811
Recruiting
Phase 1

Safety of MOON101 for the Treatment of Peanut Allergy

Peanut allergy
Moonlight Therapeutics, Inc.40 enrolled5 locationsNCT07580898
Recruiting

BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)

hazelnut allergyPeanut AllergiesHouse Dust Mite Allergy+3 more
Bühlmann Laboratories AG60 enrolled1 locationNCT07596303
Recruiting

Natural History and Genetics of Food Allergy and Related Conditions

eosinophilic esophagitisAtopic DermatitisFood allergy+1 more
National Institute of Allergy and Infectious Diseases (NIAID)1,800 enrolled1 locationNCT02504853
Recruiting
Phase 2

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

antibiotic allergyDrug hypersensitivityCephalosporin Allergy+4 more
Massachusetts General Hospital300 enrolled6 locationsNCT06406114
Recruiting
Not Applicable

Pathway to Peanut Tolerance

Food Allergy in ChildrenFood Allergy Peanut
Chinese University of Hong Kong125 enrolled1 locationNCT07592780
Recruiting
Not Applicable

EmoTIChealth: Promoting Adolescent Health Through a Serious Game.

AsthmaType 1 DiabetesAllergic Rhinitis+2 more
University of Valencia600 enrolled1 locationNCT07212530
Recruiting
Phase 2

Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children

Food allergyFood Allergy in Children
Chinese University of Hong Kong75 enrolled1 locationNCT06467994
Recruiting
Not Applicable

Diagnosing Drug Allergy: the T is the Key

Amoxicillin Allergy
University Hospital, Antwerp300 enrolled1 locationNCT06409884
Recruiting
Not Applicable

Infant Formula in Infants and Children With Cow's Milk Allergy

Cow's Milk Allergy
Abbott Nutrition61 enrolled9 locationsNCT06456541
Recruiting
Not Applicable

Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy

Food allergyCow Milk Allergy
Universitaire Ziekenhuizen KU Leuven90 enrolled5 locationsNCT06380673
Recruiting
Not Applicable

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety

Egg allergyPeanut allergyMilk Allergy, Cow's
McGill University Health Centre/Research Institute of the McGill University Health Centre360 enrolled1 locationNCT06256146
Recruiting

Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy

Allergy
Assistance Publique - Hôpitaux de Paris200 enrolled1 locationNCT07002814
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled6 locationsNCT07055542
Recruiting
Phase 1

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

Food allergy
Regeneron Pharmaceuticals6 enrolled7 locationsNCT06369467
Recruiting

Provocation After Nurse-Directed Assessment (PANDA) Study

penicillin allergydrug allergy
The University of Hong Kong440 enrolled4 locationsNCT07127835
Recruiting
Early Phase 1

LYmph Node eXamination in Cat Allergen Immunotherapy

Allergy
National Institute of Allergy and Infectious Diseases (NIAID)16 enrolled1 locationNCT07447869
Recruiting
Phase 1Phase 2

Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants

Peanut allergy
N-Fold, LLC68 enrolled1 locationNCT07117669
Recruiting
Phase 2

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

Milk and/or Peanut Allergy
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled1 locationNCT03835767